. Discovery of N -isoxazolyl biphenylsulfonamides as potent dual angiotensin II and endothelin A receptor antagonists / N. Murugesan [and others] // J. Med. Chem. 2002, 45, 3829 - 3835.
. Binary drugs: conjugates of purines and a peptide that bind to both adenosine and substance P / K.A. Jacobson [and others] // J. Med. Chem.1987, 30, 1529 - 1532.
. The PPARs: from orphan receptors to drug discovery / T.M. Willson [and others] // J. Med. Chem. 2000, 43, 527 - 550.
. Synthesis and activity of a new methoxytetrahydropyran derivative as dual cyclooxygenase-2/5-lipoxygenase inhibitor / S. Barbey [and others] // Bioorg. Med. Chem. Lett. 2002, 12, 779 - 782.
. Application of a conformationally restricted phe-leu dipeptide mimetic to the design of a combined inhibitor of angiotensin I-converting enzyme and neutral endopeptidase 24.11 / G.A. Flynn [and others] // J. Med. Chem. 1993, 36, 2420 - 2423.
. Synthesis and evaluation of «AZT -HEPT», «AZT-pyridinone», and «ddC-HEPT» conjugates as inhibitors of HIV reverse transcriptase / R. Pontikis [and others] // J. Med. Chem. 2000, 43, 1927 - 1939.
. Potent acetylcholinesterase inhibitors: design, synthesis, and structure-activity relationships of bis-interacting ligands in the galanthamine series / A. Mary [and others] // Bioorg. Med. Chem. 1998, 6, 1835 - 1850.
. Van der Schyf C.J., Geldenhuys W.J., Youdim M.B. Multifunctional drugs with different CNS targets for neuropsychiatric disorders. J. Neurochem. 2006, 99, 1033 - 1048.
. 6,6-Disubstituted hex-5-enoic acid derivatives as combined thromboxane A 2 receptor antagonists and synthetase inhibitors / R. Soyka [and others] // J. Med. Chem. 1994, 37, 26 - 39.
. Approach to dual-acting platelet activating factor (PAF) receptor antagonist/thromboxane synthase inhibitor (TxSI) based on the link of PAF antagonists and TxSIs / M. Fujita [and others] // Bioorg. Med. Chem. Lett. 2002, 12, 341 - 344.
. BW A575C a chemically novel agent with angiotensin converting enzyme inhibitor and beta-adrenoceptor-blocking properties / G. Allan [and others] // Br. J. Pharmacol. 1987, 90, 609 - 615.
. Symbiotic approach to drug design: N-[(4-Chloro-3-sulfamoylbenzamido) ethyl] propanolamine derivatives as beta-adrenergic blocking agents with diuretic activity / V. Cecchetti [and others] // Eur. J. Med. Chem. 1991, 26, 381 - 386.
. New 1-aryl-3-(4-arylpiperazin-1-yl)propane derivatives, with dual action at 5-HT1A serotonin receptors and serotonin transporter as a new class of antidepressants / J. Martinez-Esparza [and others] // J. Med. Chem. 2001, 44, 418 - 428.
. Complexes of alkylene-linked tacrine dimers with Torpedo californica acetylcholinesterase: Binding of Bis5-tacrine produces a dramatic rearrangement in the active-site gorge / E.H. Rydberg [and others] // J. Med. Chem. 2006, 49, 5491 - 5500.
. A novel arginine methyltransferase inhibitor with cellular activity / A. Spannhoff [and others] // Bioorg. Med. Chem. Lett. 2007, 17, 4150 - 4153.
. Structural basis of inhibition of the human NAD+ -dependent deacetylase SIRT5 by suramin / A. Schuetz [and others] // Structure, 2007, 15, 377 - 389.
. Heterodimers of G protein-coupled receptors as novel and distinct drug targets / R. Rozenfeld [and others] // Drug Discov. Today, 2006, 3, 437 - 443.
. Filizola M., Wang S.X., Weinstein H. Dynamic models of G-protein coupled receptor dimers: indications of asymmetry in the rhodopsin dimer from molecular dynamics simulations in a POPC bilayer. J. Comput. Aided Mol. Des. 2006, 20, 405 - 416.